Podcast: SaMD Series: What Should Tech Companies Know?

FH
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Contributor

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP is a law firm dedicated to advancing ideas, discoveries, and innovations that drive businesses around the world. From offices in the United States, Europe, and Asia, Finnegan works with leading innovators to protect, advocate, and leverage their most important intellectual property (IP) assets.
Software as a Medical Device – also referred to as SaMD – is one of the fastest growing innovations in the medical device industry.
United States Intellectual Property

Software as a Medical Device – also referred to as SaMD – is one of the fastest growing innovations in the medical device industry. As with any technology that experiences rapid adoption, challenges related to intellectual property protection often follow. In this series, we take a close look at IP considerations that SaMD developers should be aware of as they enter this market. In this podcast, Finnegan attorneys Susan Tull and Cory Bell explore challenges tech companies may face when developing SaMD.

To listen to the podcast, please click here

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More